MDS Inc.
Science Advancing Health
Home
Our Company
Our Markets
Our Businesses
For Investors
For Media
For Potential Employees
News Releases
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Recent Quarterly Results
Media Contact information
MDS Media Backgrounder
Webcasts & Presentations
Calendar of Events
Annual Report
Biographies
Photo and Graphics Gallery
Subscribe
Investor Overview
Stock Info
Stock Quote
Historical Price Lookup
Investment Calculator
Dividend Info
Financial Reports
Archives
SEDAR
EDGAR
Calendar of Events
News Releases
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Webcasts & Presentations
Directors & Management
Board of Directors
Executive Management Team
Corporate Governance
Annual Report
Proxy Circular
Board of Directors
Compensation of Directors
Board and Committee Charters
Guidelines & Practices
Disclosure Required by Section 303A.11 of NYSE
Global Business Practice Standards
Frequently Asked Questions
General Investor FAQs
Investor Kit
Investor Relations Contacts
CONTACT US
News Releases 2001
12-18-2001
Duke University Health System and MDS Laboratories sign Multi-Year Agreement
12-13-2001
MDS Reports Fourth Quarter and Fiscal 2001 Results
12-12-2001
New Chemogenomics Alliance Between MDS Pharma Services and Iconix Pharmaceuticals
12-11-2001
MDS Proteomics Names Anil K. Amlani Chief Financial Officer; Amlani Brings More Than 20 Years of Financial Expertise to MDS Proteomics
11-28-2001
MDS Technology Key to Anti-rejection Drug Monitoring Test
11-13-2001
Ventiv Health, MDS Pharma Services and Paul Capital Partners Form Strategic Alliance to Serve Life Sciences Industry
11-06-2001
MDS Inc. Appoints Clarence J. Chandran to the Board
11-05-2001
MDS Nordion Introduces Oncentra(TM) Oncology Information Management
10-08-2001
MDS Proteomics Extends Relationship to University of Southern Denmark Under the Direction of Dr. Matthias Mann
09-19-2001
MDS Reports Third Quarter Results
09-19-2001
MDS Inc. Third Quarter F2001 Management's discussion and analysis of operating results and financial position
09-11-2001
MDS Inc. Appoints IBM Executive to Board
08-27-2001
MDS Completes Integration of Life Sciences Businesses
08-15-2001
MDS and Signature Form Strategic Alliance to Develop and Commercialize Novel Drug Discovery Instrumentation
07-31-2001
MDS SCIEX Appoints New Senior Vice-President
07-30-2001
MDS Proteomics Unveils PepSea Technology, Enabling Targeted, High-Speed Protein Identification
07-24-2001
MDS Pharma Services Launches Revolutionary, Internet-Based Data Delivery Platform, MDS Pharma Express, for Discovery and Preclinical
07-11-2001
Cubist Pharmaceuticals Chairman and CEO Scott Rocklage Appointed to MDS Proteomics' Board of Directors
07-05-2001
Allergy Testing Simplified for Patients
06-29-2001
MDS Proteomics and Abgenix Announce Exclusive Agreement to Develop Proteomic-Based Antibody Therapies
06-24-2001
MDS Nordion Invests $20 Million to Build New Commercial Cyclotron
06-22-2001
MDS Inc. Adds Pharma Executive to Board
06-19-2001
MDS Inc. Normal Course Issuer Bid
06-14-2001
MDS Reports Second Quarter Results
06-14-2001
MDS Capital Corp and Acqua Wellington Announce Formation of Vengate Capital Partners
06-12-2001
MDS Creates a Specialty Diagnostic Service for all Canadians
06-11-2001
MDS Nordion Receives FDA Clearance for its New Inverse Planning Software for IMRT
05-29-2001
PerkinElmer and MDS Sciex to Develop Next Generation TOF Mass Spectrometry Solutions for Proteomics
05-22-2001
Agilent Technologies and MDS Proteomics Work Together to Speed Protein Analysis and Drug Development
03-27-2001
MDS Inc. Announcement
03-27-2001
MDS Proteomics and Partners HealthCare Form Clinical Alliance to Speed the Discovery of New Medicines
03-20-2001
MDS Proteomics Expands Denmark and Toronto Facilities to Meet High Demand for Proteomics Research; Boston and Charlottesville Facilities to Follow
03-08-2001
MDS Reports Continued Growth in First Quarter
02-14-2001
MDS Introduces New Cervical Cancer Test
01-30-2001
Global Technology Leader - MDS Sciex - Breaks Unprecedented Ground In India
01-25-2001
MDS Creates Canadian e-Health Platform for Physicians
01-25-2001
Micralyne and MDS Sciex Announce Microfluidics R and D Agreement